Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Clinical Oncology

• Publication date

  2007-03-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2006.08.7916PMID 17369573
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regression of liver metastases following treatment with yttrium-90 microspheres.

  2010cited by this paper
• Towards a pan-European consensus on the treatment of patients with colorectal liver metastases.

  2006cited by this paper
• Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study.

  2005cited by this paper
• Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.

  2005cited by this paper
• A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer.

  2005cited by this paper
• Treatment of liver metastases of colorectal cancer.

  2005cited by this paper
• Short- and-long term results of intraoperative radiofrequency ablation of liver metastases

  2005cited by this paper
• Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial.

  2005cited by this paper
• In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line

  2005cited by this paper
• Treatment of liver metastases of colorectal cancer.

  2005cited by this paper
• Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies

  2005cited by this paper
• Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.

  2004cited by this paper
• Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

  2004cited by this paper
• Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

  2004cited by this paper
• Salvage Surgery Following Downstaging of Unresectable Hepatocellular Carcinoma

  2004cited by this paper
• Randomised phase 2 trial of SIR‐Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer

  2004cited by this paper
• A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

  2004cited by this paper
• Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients

  2004cited by this paper
• Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis

  2004cited by this paper
• Cellular and molecular pharmacology of oxaliplatin.

  2002cited by this paper
• Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer.

  2002cited by this paper
• Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial.

  2001cited by this paper
• Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer.

  2001cited by this paper
• Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases

  2001cited by this paper
• Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy.

  2001cited by this paper
• Effect of selective internal radiation therapy and hepatic arterial chemotherapy on normal liver volume and spleen volume

  2001cited by this paper
• Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.

  2000cited by this paper
• The Brisbane 2000 terminology of liver anatomy and resections.

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors

  2000cited by this paper
• Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

  2000cited by this paper
• 202 Oxaliplatin: In vitro evidence of its radiation sensitizing activity — preclinical observations relevant to clinical trials

  1999cited by this paper
• Size quantification of liver metastases in patients undergoing cancer treatment: reproducibility of one-, two-, and three-dimensional measurements determined with spiral CT.

  1997cited by this paper
• Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin.

  1997cited by this paper
• Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors.

  1995cited by this paper
• Diagnostic pharmaco-scintigraphy with hepatic intra-arterial technetium-99m macroaggregated albumin in the determination of tumour to non-tumour uptake ratio in hepatocellular carcinoma.

  1994cited by this paper
• A phase I dose escalation trial of yttrium‐90 microspheres in the treatment of primary hepatocellular carcinoma

  1992cited by this paper
• Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

  1989cited by this paper
• The clinical correlation of an autopsy study of recurrent colorectal cancer.

  1979cited by this paper
• Comparison of Histologic and Colposcopic Findings in DES-Exposed Females

  1978cited by this paper
• BETA RADIATION OF CIRCULATING BLOOD BY AN IMPLANTED SHIELDED Y90 SOURCE, PRELIMINARY REPORT OF TECHNIQUE.

  1964cited by this paper

• Interventional Oncology for Colorectal Liver Metastases: From Local Cure to Salvage Therapy

  2025cites this paper
• TARE-Induced Pan-Immune Inflammation Value as a Prognostic Biomarker in Liver-Dominant Metastatic Colorectal Cancer

  2025cites this paper
• Pharmacological Enhancement of Radionuclide Therapy Using Radiopharmaceutical-Drug Combinations in Oncology.

  2025cites this paper
• ACR-ABS-ACNM-ARS-SIR-SNMMI Practice Parameter for Radioembolization of Liver Malignancies.

  2025cites this paper
• Consensus statement on safety of combining transarterial radioembolization with 90yttrium microspheres with systemic anticancer agents for the treatment of liver malignancy.

  2024cites this paper
• Radioembolization of HCC and secondary hepatic tumors: a comprehensive review.

  2024cites this paper
• Complications Related to Transarterial Treatment of Hepatocellular Carcinoma: A Comprehensive Review

  2023cites this paper
• Upper-critical solution temperature (UCST) polymer functionalized nanomedicine for controlled drug release and hypoxia alleviation in hepatocellular carcinoma therapy

  2023cites this paper
• Integrated Capecitabine–Temozolomide with Radioembolization for Liver-Dominant G2 NETs: Long-Term Outcomes of a Single-Institution Retrospective Study

  2023cites this paper
• Yttrium-90 for colorectal liver metastasis - the promising role of radiation segmentectomy as an alternative local cure

  2022cites this paper
• EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds

  2022cites this paper
• Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin

  2021cites this paper
• Metastasectomy for Stage IVA Colon Cancer: Does the Type of Treating Institution Make a Difference?

  2021cites this paper
• Multimodales Management nichtresektabler Lebermetastasen – neue Therapieoptionen mit Ausblick auf sekundäre Resektion

  2021cites this paper
• Two-stage hepatectomy with radioembolization for bilateral colorectal liver metastases: A case report

  2021cites this paper
• Radioembolization for Hepatocellular Carcinoma

  2021cites this paper
• Narrative review of the role of yttrium-90 selective internal radiation therapy in the surgical management of colorectal liver metastases.

  2021cites this paper
• ACR-ABS-ACNM-ASTRO-SIR-SNMMI practice parameter for selective internal radiation therapy or radioembolization for treatment of liver malignancies.

  2021cites this paper
• Transarterial Radioembolization: Patient Selection and Microsphere Characteristics

  2021cites this paper
• Transarterial Radioembolization in Patients With Unresectable Colorectal Cancer Liver Metastases.

  2021cites this paper
• Cancer Regional Therapy: HAI, HIPEC, HILP, ILI, PIPAC and Beyond

  2020cites this paper
• Diagnosis, pathophysiology, and treatment of SIRT-induced gastroduodenal ulcers: A systematic literature review.

  2020cites this paper
• Interventional Radiology in Management of Colorectal Carcinoma Metastasis

  2020cites this paper
• Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm.

  2020cites this paper
• IPN Systems for Cancer Therapy

  2020cites this paper
• Evidence-Based Integration of Yttrium-90 Radioembolization in the Contemporary Management of Hepatic Metastases from Colorectal Cancer.

  2019cites this paper
• Factors Affecting Oncologic Outcomes of 90Y Radioembolization of Heavily Pre‐Treated Patients With Colon Cancer Liver Metastases

  2019cites this paper
• Chapter 4 Local Treatment Options for Unresectable Liver Metastases in Colorectal Cancer

  2019cites this paper
• Radionuclide Therapy for Tumors of the Liver and Biliary Tract

  2019cites this paper
• Selective Internal Radiation Therapy in the Multidisciplinary Management of Liver Metastases From Colorectal Carcinoma.

  2019cites this paper
• Percutaneous Transcatheter Particle Therapies

  2019cites this paper
• Liver Resection After Selective Internal Radiation Therapy with Yttrium-90: Safety and Outcomes

  2019cites this paper
• Hepatic Resection Following Selective Internal Radiation Therapy for Colorectal Cancer Metastases in the FOXFIRE Clinical Trial: Clinical Outcomes and Distribution of Microspheres

  2019influential citation
• Single-institution experience with selective internal radiation therapy (SIRT) for the treatment of unresectable colorectal liver metastases

  2019cites this paper
• Liver-Directed and Systemic Therapies for Colorectal Cancer Liver Metastases

  2019cites this paper
• Role of Y90 Radioembolization in Hepatic Metastatic Colorectal Carcinoma

  2019cites this paper
• Selective Internal Radiotherapy (SIRT) of Primary Hepatic Carcinoma and Liver Metastases

  2019cites this paper
• Outcomes of Radioembolization in Patients with Chemorefractory Colorectal Cancer Liver Metastasis: a Single-Center Experience

  2019cites this paper
• A pilot study of intrahepatic yttrium‐90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver‐only metastases

  2019cites this paper
• Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer

  2018cites this paper
• Genomic mutations and histopathologic biomarkers in Y90 radioembolization for chemorefractory colorectal liver metastases

  2018cites this paper
• Histopathological changes resulting from selective internal radiotherapy (SIRT)

  2018cites this paper
• Liver Resection for Colorectal Hepatic Metastases after Systemic Chemotherapy and Selective Internal Radiation Therapy with Yttrium-90 Microspheres: A Systematic Review

  2018cites this paper
• Hepatic Arterial Therapy for Colorectal Cancer Liver Metastases

  2018cites this paper
• Report from the 19th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29-30 September 2017.

  2018cites this paper
• The role of interventional oncology in the treatment of colorectal cancer liver metastases

  2018cites this paper
• Safety and Feasibility of Integrating Yttrium-90 Radioembolization With Capecitabine-Temozolomide for Grade 2 Liver-Dominant Metastatic Neuroendocrine Tumors

  2018cites this paper
• Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know

  2018cites this paper
• 90Y Resin Microspheres Radioembolization for Colon Cancer Liver Metastases Using Full-Strength Contrast Material

  2018cites this paper
• Local Treatment Options for Unresectable Liver Metastases in Colorectal Cancer

  2018cites this paper
• Radioembolization of Hepatic Metastases with 90 Y-Microspheres: Indications and Procedure

  2018cites this paper
• Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes

  2017influential citation
• Molecular radiotheragnostics in thyroid disease

  2017cites this paper
• First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

  2017cites this paper
• Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases.

  2017cites this paper
• The need for multidisciplinarity in specialist training to optimize future patient care

  2017cites this paper
• Selective internal radiation therapy for liver tumours

  2017cites this paper
• Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data

  2017cites this paper
• Radioembolization with yttrium-90 microspheres

  2017cites this paper
• S3-Leitlinie – Kolorektales Karzinom

  2017cites this paper
• Yttrium-90 Radioembolization as Salvage Therapy for Liver Metastases From Colorectal Cancer

  2017cites this paper
• Adequate SIRT activity dose is as important as adequate chemotherapy dose - Authors' reply.

  2017cites this paper
• Adequate SIRT activity dose is as important as adequate chemotherapy dose.

  2017cites this paper
• Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and Future Directions.

  2017cites this paper
• Radiation therapy for liver metastases: Clinical data

  2017cites this paper
• Radiation Therapy for Colorectal Liver Metastases

  2017cites this paper
• Tumor Vascularity Does Not Predict Response to Yttrium-90 Radioembolization for Hepatic Metastases from Colorectal Cancer

  2017cites this paper
• Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases.

  2017cites this paper
• A single institute retrospective trial of concurrent chemotherapy with SIR-Spheres® versus SIR-Spheres® alone in chemotherapy-resistant colorectal cancer liver metastases.

  2017cites this paper
• Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma

  2017cites this paper
• Yttrium-90 Selective Internal Radiation Therapy

  2017cites this paper
• Liver-directed therapy in metastatic colorectal cancer

  2017cites this paper
• Radioembolization in Colorectal Metastases: A Review

  2017cites this paper
• Correction: Radioembolisation mit Yttrium-90-Mikrosphären

  2017cites this paper
• The role of image-guided therapy in the management of colorectal cancer metastatic disease.

  2017cites this paper
• Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.

  2017cites this paper
• Yttrium-90 Radioembolization for Metastatic Colorectal Cancer: Outcomes by Number of Lines of Therapy

  2017cites this paper
• Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review).

  2017cites this paper
• Radioembolisation mit Yttrium-90-Mikrosphären

  2017cites this paper
• Evidence-Based Review of Nonsurgical Management of Colorectal Cancer Liver Metastasis and Evolving Role of Interventional Radiology

  2017cites this paper
• New Developments in Interventional Oncology: Liver Metastases From Colorectal Cancer

  2016cites this paper
• Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.

  2016cites this paper
• The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres

  2016cites this paper
• Selective internal radiation therapy for liver metastases from colorectal cancer.

  2016cites this paper
• Landmark study raises the bar for interventional oncology.

  2016cites this paper
• Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry

  2016cites this paper
• Gastrointestinal cancer: Light and shade of intrahepatic arterial radiotherapy in mCRC

  2016cites this paper
• Perspective on therapeutic application of selective internal radiotherapy in colorectal cancer liver metastasis

  2016cites this paper
• Treatments for colorectal liver metastases: A new focus on a familiar concept.

  2016cites this paper
• Translational radionanomedicine: a clinical perspective

  2016cites this paper
• Radioembolization as a salvage therapy for heavily pre-treated patients with colorectal cancer liver metastases: factors affecting outcomes

  2016cites this paper
• Diagnostic Applications of Nuclear Medicine: Colorectal Cancer

  2016cites this paper
• Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases.

  2016cites this paper
• Advances in selective internal radiotherapy for primary and secondary liver cancer

  2016cites this paper
• SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.

  2016cites this paper
• Preliminary Investigation of Rare Earth Elements Ion Exchange on Zeolites

  2016cites this paper
• Current status of transarterial radioembolization.

  2016cites this paper
• Radionuclide Therapy of Tumors of the Liver and Biliary Tract

  2016cites this paper
• Radioembolization as a Treatment Strategy for Metastatic Colorectal Cancer to the Liver: What Can We Learn from the SIRFLOX Trial?

  2016cites this paper
• Selective Internal Radiation Therapy/Yttrium-90: Have We Found Its Place?

  2016cites this paper